Literature DB >> 15303006

Effect of high-dose vitamins, coenzyme Q and high-fat diet in paediatric patients with mitochondrial diseases.

J Panetta1, L J Smith, A Boneh.   

Abstract

We reviewed the medical records of all patients with confirmed mitochondrial diseases treated with any or all of thiamin, riboflavin, coenzyme Q, vitamin C (approximately 10 mg/kg per day) and a high-fat diet (50-60% of caloric intake) between 1997 and 2003. There were 15 patients (9 male): 10 had enzymatic deficiency and 10 had a molecular diagnosis. Age at diagnosis was 11 months to 17 years 10 months. Treatment was commenced at time of clinical diagnosis in 12 patients. Follow-up period was 3 days to 7 years (median 22 months). Improvement was reported in 9 patients, of whom 4 attained further developmental skills, but this was only temporary in 6 patients. Five patients died during the follow-up period (3 days to 7 years). Patients with the 3243A > G mutation showed no significant change in the course of their disease, except for fewer migraine attacks. Of the six patients who had seizures, one has had a significant reduction in the severity of the seizures and one has had no further seizures. Plasma lactate levels were noncontributory. We conclude that high-dose vitamin and cofactor treatment and, where applicable, high-fat diet, are well tolerated and possibly effective in the short term, but ineffective in the longer term.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15303006     DOI: 10.1023/B:BOLI.0000037354.66587.38

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  28 in total

1.  Coenzyme Q10 improves psychiatric symptoms in adult-onset mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes: a case report.

Authors:  T Shinkai; M Nakashima; O Ohmori; T Terao; J Nakamura; N Hiramatsu; H Hashiguchi; S Tsuji
Journal:  Aust N Z J Psychiatry       Date:  2000-12       Impact factor: 5.744

2.  MELAS syndrome with mitochondrial tRNA(Leu)(UUR) mutation: correlation of clinical state, nerve conduction, and muscle 31P magnetic resonance spectroscopy during treatment with nicotinamide and riboflavin.

Authors:  A M Penn; J W Lee; P Thuillier; M Wagner; K M Maclure; M R Menard; L D Hall; N G Kennaway
Journal:  Neurology       Date:  1992-11       Impact factor: 9.910

3.  Triacylglycerol infusion improves exercise endurance in patients with mitochondrial myopathy due to complex I deficiency.

Authors:  Mark J Roef; Kees de Meer; Dirk-Jan Reijngoud; Helma W H C Straver; Martina de Barse; Satish C Kalhan; Ruud Berger
Journal:  Am J Clin Nutr       Date:  2002-02       Impact factor: 7.045

4.  The treatment of mitochondrial myopathies and encephalomyopathies.

Authors:  P L Peterson
Journal:  Biochim Biophys Acta       Date:  1995-05-24

5.  Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial.

Authors:  J Schoenen; J Jacquy; M Lenaerts
Journal:  Neurology       Date:  1998-02       Impact factor: 9.910

Review 6.  Function of coenzyme Q in the cell: some biochemical and physiological properties.

Authors:  H Rauchová; Z Drahota; G Lenaz
Journal:  Physiol Res       Date:  1995       Impact factor: 1.881

7.  Menadione partially restores NADH-oxidation and ATP-synthesis in complex I deficient fibroblasts.

Authors:  F A Wijburg; N Feller; C J de Groot; R J Wanders
Journal:  Biochem Int       Date:  1990-10

8.  Electron-transfer restoration by vitamin K3 in a complex III-deficient mutant of S. cerevisiae and sequence of the corresponding cytochrome b mutation.

Authors:  P Brivet-Chevillotte; J P di Rago
Journal:  FEBS Lett       Date:  1989-09-11       Impact factor: 4.124

9.  Riboflavin-responsive complex I deficiency.

Authors:  H R Scholte; H F Busch; H D Bakker; J M Bogaard; I E Luyt-Houwen; L P Kuyt
Journal:  Biochim Biophys Acta       Date:  1995-05-24

10.  Coenzyme Q10 with multiple vitamins is generally ineffective in treatment of mitochondrial disease.

Authors:  P M Matthews; B Ford; R J Dandurand; D H Eidelman; D O'Connor; A Sherwin; G Karpati; F Andermann; D L Arnold
Journal:  Neurology       Date:  1993-05       Impact factor: 9.910

View more
  13 in total

1.  Classical MERRF phenotype associated with mitochondrial tRNA(Leu) (m.3243A>G) mutation.

Authors:  Florian Brackmann; Angela Abicht; Uwe Ahting; Rolf Schröder; Regina Trollmann
Journal:  Eur J Pediatr       Date:  2012-01-25       Impact factor: 3.183

Review 2.  Mitochondrial energetics and therapeutics.

Authors:  Douglas C Wallace; Weiwei Fan; Vincent Procaccio
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

3.  Insulin and insulin resistance.

Authors:  Gisela Wilcox
Journal:  Clin Biochem Rev       Date:  2005-05

Review 4.  Therapies in inborn errors of oxidative metabolism.

Authors:  Manuel Schiff; Paule Bénit; Howard T Jacobs; Jerry Vockley; Pierre Rustin
Journal:  Trends Endocrinol Metab       Date:  2012-05-25       Impact factor: 12.015

Review 5.  Recent topics: the diagnosis, molecular genesis, and treatment of mitochondrial diseases.

Authors:  Kei Murayama; Masaru Shimura; Zhimei Liu; Yasushi Okazaki; Akira Ohtake
Journal:  J Hum Genet       Date:  2018-11-21       Impact factor: 3.172

6.  Mitochondrial disease patients' perception of dietary supplements' use.

Authors:  Amel Karaa; Joshua Kriger; Johnston Grier; Amy Holbert; John L P Thompson; Sumit Parikh; Michio Hirano
Journal:  Mol Genet Metab       Date:  2016-07-16       Impact factor: 4.797

Review 7.  Treatment for mitochondrial disorders.

Authors:  Gerald Pfeffer; Kari Majamaa; Douglass M Turnbull; David Thorburn; Patrick F Chinnery
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18

Review 8.  Diagnosis and treatment of mitochondrial myopathies.

Authors:  Gerald Pfeffer; Patrick F Chinnery
Journal:  Ann Med       Date:  2011-08-25       Impact factor: 4.709

9.  Mouse studies to shape clinical trials for mitochondrial diseases: high fat diet in Harlequin mice.

Authors:  Manuel Schiff; Paule Bénit; Riyad El-Khoury; Dimitri Schlemmer; Jean-François Benoist; Pierre Rustin
Journal:  PLoS One       Date:  2011-12-13       Impact factor: 3.240

Review 10.  New treatments for mitochondrial disease-no time to drop our standards.

Authors:  Gerald Pfeffer; Rita Horvath; Thomas Klopstock; Vamsi K Mootha; Anu Suomalainen; Saskia Koene; Michio Hirano; Massimo Zeviani; Laurence A Bindoff; Patrick Yu-Wai-Man; Michael Hanna; Valerio Carelli; Robert McFarland; Kari Majamaa; Douglas M Turnbull; Jan Smeitink; Patrick F Chinnery
Journal:  Nat Rev Neurol       Date:  2013-07-02       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.